ss_321

A subsequent new drug license is required for approval of new dosage forms, new routes of administration, or new indications of an already approved drug. It ensures regulatory compliance, safety, and efficacy before market entry, as per CDSCO guidelines under India's Drugs and Cosmetics Rules.